Hormone therapyFDA-approvedFirst-line
Leuprolide
How it works
Blocks the production of testosterone, a hormone that fuels prostate cancer growth.
Cancer types
Prostate Cancer— All patients
Efficacy
Studies show that leuprolide can reduce testosterone levels to near-zero, leading to significant tumor shrinkage in many patients.
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Evaluating Relugolix vs Leuprolide on Heart Health in Prostate Cancer Patients | Prostate Cancer | phase-2 | — | Source → |
| Enzalutamide Monotherapy for Prostate Cancer | Prostate Cancer | phase-3 | The 5-year probability rate of overall survival was 89.5% for enzalutamide monotherapy vs 87.2% for leuprolide alone. | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.